William D. Travis

137.4k total citations · 32 hit papers
546 papers, 56.6k citations indexed

About

William D. Travis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, William D. Travis has authored 546 papers receiving a total of 56.6k indexed citations (citations by other indexed papers that have themselves been cited), including 336 papers in Pulmonary and Respiratory Medicine, 174 papers in Oncology and 88 papers in Epidemiology. Recurrent topics in William D. Travis's work include Lung Cancer Treatments and Mutations (145 papers), Lung Cancer Diagnosis and Treatment (127 papers) and Lung Cancer Research Studies (96 papers). William D. Travis is often cited by papers focused on Lung Cancer Treatments and Mutations (145 papers), Lung Cancer Diagnosis and Treatment (127 papers) and Lung Cancer Research Studies (96 papers). William D. Travis collaborates with scholars based in United States, Japan and United Kingdom. William D. Travis's co-authors include Valerie W. Rusch, E. Brambilla, Thomas V. Colby, Natasha Rekhtman, Élisabeth Brambilla, Prasad S. Adusumilli, Camelia S. Sima, B Corrin, Yukío Shimosato and Gregory J. Riely and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

William D. Travis

539 papers receiving 55.3k citations

Hit Papers

Wegener Granulomatosis: An Analysis of 158 Patients 1986 2026 1999 2012 1992 2017 2004 1999 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William D. Travis United States 122 34.4k 17.7k 8.6k 7.7k 6.5k 546 56.6k
Murray F. Brennan United States 143 43.3k 1.3× 38.6k 2.2× 8.3k 1.0× 5.6k 0.7× 31.6k 4.8× 954 81.0k
Razelle Kurzrock United States 119 12.3k 0.4× 24.9k 1.4× 5.0k 0.6× 21.0k 2.7× 4.5k 0.7× 1.2k 60.4k
Christopher D.�M. Fletcher United States 125 41.3k 1.2× 20.1k 1.1× 3.6k 0.4× 10.0k 1.3× 15.0k 2.3× 674 70.0k
Richard Kaplan United Kingdom 48 20.2k 0.6× 22.4k 1.3× 3.9k 0.5× 7.3k 0.9× 7.8k 1.2× 173 46.0k
Maria J. Merino United States 98 17.3k 0.5× 8.1k 0.5× 2.1k 0.2× 12.3k 1.6× 5.5k 0.8× 593 37.5k
Jaap Verweij Netherlands 100 22.3k 0.6× 28.2k 1.6× 3.1k 0.4× 13.7k 1.8× 8.8k 1.4× 621 55.4k
W. Marston Linehan United States 113 20.9k 0.6× 7.5k 0.4× 2.4k 0.3× 22.2k 2.9× 7.9k 1.2× 586 44.9k
Luigi Mariani Italy 84 8.8k 0.3× 10.6k 0.6× 3.4k 0.4× 6.6k 0.9× 7.5k 1.2× 451 32.0k
Christine M. Lohse United States 90 16.4k 0.5× 7.0k 0.4× 4.9k 0.6× 11.2k 1.5× 8.7k 1.3× 618 32.3k
Elaine S. Jaffe United States 122 4.4k 0.1× 28.2k 1.6× 5.5k 0.6× 8.6k 1.1× 4.2k 0.6× 720 63.1k

Countries citing papers authored by William D. Travis

Since Specialization
Citations

This map shows the geographic impact of William D. Travis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Travis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Travis more than expected).

Fields of papers citing papers by William D. Travis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William D. Travis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Travis. The network helps show where William D. Travis may publish in the future.

Co-authorship network of co-authors of William D. Travis

This figure shows the co-authorship network connecting the top 25 collaborators of William D. Travis. A scholar is included among the top collaborators of William D. Travis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William D. Travis. William D. Travis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fick, Cameron N., Kay See Tan, Gaetano Rocco, et al.. (2024). High-risk features associated with recurrence in stage I lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 169(2). 436–444.e6. 10 indexed citations
2.
3.
Nicholson, Andrew G., Ming‐Sound Tsao, Mary Beth Beasley, et al.. (2021). The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. Journal of Thoracic Oncology. 17(3). 362–387. 752 indexed citations breakdown →
4.
Laddha, Saurabh V., Edaise M. da Silva, Kenneth Robzyk, et al.. (2019). Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids. Cancer Research. 79(17). 4339–4347. 50 indexed citations
5.
Chang, Jason C., Deepu Alex, Matthew J. Bott, et al.. (2019). Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clinical Cancer Research. 25(23). 7113–7125. 67 indexed citations
6.
Girard, Luc, Jaime Rodriguez‐Canales, Carmen Behrens, et al.. (2016). An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(19). 4880–4889. 132 indexed citations
7.
Rekhtman, Natasha, M. Catherine Pietanza, Matthew D. Hellmann, et al.. (2016). Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets. Clinical Cancer Research. 22(14). 3618–3629. 325 indexed citations breakdown →
8.
Kiess, Ana P., Hangjun Wang, William D. Travis, & Joachim Yahalom. (2015). Sarcoid in cancer patients: clinical characteristics and associated disease status.. PubMed. 32(3). 200–7. 9 indexed citations
9.
Travis, William D.. (2015). WHO classification of tumours of the lung, pleura, thymus and heart. 1173 indexed citations breakdown →
10.
Yeh, Yi‐Chen, Jun‐ichi Nitadori, Kyuichi Kadota, et al.. (2014). Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement. Histopathology. 66(7). 922–938. 112 indexed citations
11.
Kachala, Stefan S., Adam J. Bograd, Jonathan Villena‐Vargas, et al.. (2013). Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma. Clinical Cancer Research. 20(4). 1020–1028. 132 indexed citations
12.
Rekhtman, Natasha, Paul K. Paik, Maria E. Arcila, et al.. (2012). Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR / KRA S and Presence of PIK3CA / AKT1 Mutations. Clinical Cancer Research. 18(4). 1167–1176. 289 indexed citations
13.
Pietanza, M. Catherine, Kyuichi Kadota, Kety Huberman, et al.. (2012). Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker. Clinical Cancer Research. 18(4). 1138–1145. 122 indexed citations
14.
Suzuki, Kei, Stefan S. Kachala, Kyuichi Kadota, et al.. (2011). Prognostic Immune Markers in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(16). 5247–5256. 147 indexed citations
15.
Girard, Nicolas, Ronglai Shen, Tianhua Guo, et al.. (2009). Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas. Clinical Cancer Research. 15(22). 6790–6799. 147 indexed citations
16.
Girard, Nicolas, Irina Ostrovnaya, Christopher Lau, et al.. (2009). Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers. Clinical Cancer Research. 15(16). 5184–5190. 112 indexed citations
17.
Yoshizawa, Akihiko, Junya Fukuoka, Shigeki Shimizu, et al.. (2009). Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(1). 240–248. 127 indexed citations
18.
Jeon, Hyo-Sung, Tatiana Dracheva, Daoud Meerzaman, et al.. (2008). SMAD6 Contributes to Patient Survival in Non–Small Cell Lung Cancer and Its Knockdown Reestablishes TGF-β Homeostasis in Lung Cancer Cells. Cancer Research. 68(23). 9686–9692. 51 indexed citations
19.
20.
Matsui, Kazuhiro, Kazuyo Takeda, Zu‐Xi Yu, et al.. (2000). Downregulation of Estrogen and Progesterone Receptors in the Abnormal Smooth Muscle Cells in Pulmonary Lymphangioleiomyomatosis Following Therapy: An Immunohistochemical Study. American Journal of Respiratory and Critical Care Medicine. 161(3). 1002–1009. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026